Former NFL quarterback Tom Brady said on Tuesday that his dog, Junie, is a clone of his late pet, Lua, who passed away two years ago. The pit bull mix was shared by Brady with his ex-wife, Gisele ...

Colossal Biosciences, which Brady is an investor in, cloned the pit bull mix using a blood sample collected prior to her death Tom Brady/Instagram; Backgrid Tom Brady's dog Junie is a clone of his dog ...

Brady said his family was "given a second chance" with Lua, who died in 2023. Retired NFL star Tom Brady said this week that his dog Junie is a clone of his late dog Lua. In a statement shared Tuesday ...

Tom Brady's new pup has a surprising origin story. The seven-time Super Bowl champion revealed on Tuesday that his dog Junie is actually a clone of his late pit bull mix, Lua, a beloved family pet he ...

Former NFL quarterback Tom Brady has an extensive list of endeavors outside of football, and one of them led to a unique development for his family. Per Bailey Richards of People, Brady revealed on ...

Recently, NSFOCUS CERT detected that Redis issued a security bulletin and fixed the Redis Lua code execution vulnerability (CVE-2025-49844); Because Redis’s Lua script engine has a use-after-free ...

As part of her graduation announcement, Lua Asuka went over her plans for her last month as a Vtuber. She noted she will stream as usual between April 29, 2025 and May 30, 2025. Her last stream will ...

Lung cancer can be treated with small molecules formulated as pills as well as biological medications that are injected or infused, both as standalone treatments or as part of drug combinations. A ...

Optune Lua is FDA approved for use with immunotherapy or docetaxel in metastatic stage IV NSCLC post-platinum treatment. The device uses tumor treating fields to disrupt cancer cell division, offering ...

The Food and Drug Administration on Tuesday approved a new device to treat non-small cell lung cancer, Novocure’s Optune Lua, which creates electric fields that its manufacturer says disrupts ...

The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...